StonvexLoading…
StonvexStonvexStonvexCore line items from DOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.09B | $7.75B | $7.68B | $7.84B |
Operating Income | $1.37B | $1.21B | $1.22B | $1.28B |
Net Income | $1.09B | $2.70B | $1.06B | $1.07B |
EPS (Diluted) | $7.94 | $19.45 | $7.52 | $7.42 |
Total Assets | $13.42B | $12.51B | $11.35B | $10.90B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.68B | $1.84B | $398.56M | $380.87M |
Free Cash Flow OCF − CapEx | $1.12B | $920.30M | $1.15B | $594.64M |
Shares Outstanding | 137.78M | 138.70M | 140.60M | 143.59M |